Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
•
Gastroesophageal Cancer
How would you treat a patient with adenocarcinoma of the GE junction in the setting of interstitial lung disease?
Is neoadjuvant chemoradiation or perioperative chemotherapy preferred?
Answer from: Radiation Oncologist at Academic Institution
Protons.
Sign in or Register to read more
6623
Related Questions
Would you consider proton therapy as part of TNT for rectal cancer?
When treating pancreatic body/tail lesions that result in significant dose spread to the spleen, what is your threshold to offer pneumococcal, hemophilus influenza, and meningococcal vaccines?
How do you manage oxaliplatin-induced splenomegaly?
What is your approach to high-grade neuroendocrine tumor of the stomach?
Would you consider chemo-RT for duodenal adenocarcinoma s/p resection with at least 1 cm positive margin in a patient with a history of Crohn's disease?
Do you use more stringent liver constraints when treating HCC with SBRT in patients who are CP B8/9 or C?
What treatment sequence do you follow for patients with rectal cancer who are candidates for both PROSPECT and TNT/Watch and wait?
In a patient with prior RT to the prostate and SVs and newly diagnosed, locally advanced rectal cancer at 10-15 cm, would you offer preoperative chemoradiation?
When treating with SBRT and immunotherapy for unresectable HCC, how do you sequence the treatment?
When treating rectal cancer with TNT and induction chemotherapy first, do you repeat pelvic MRI prior to planning for chemoradiation?